Antikörperblockade von VLA-4 beeinflusst die Leukozyten-Endothelzell-Interaktion und wirkt entzündungshemmend im DSS-Mausmodell chronisch entzündlicher Darmerkrankungen

  • Mike G. Laukötter
  • E. Rijcken
  • C. Anthoni
  • S. Meier
  • D. Vestweber
  • N. Senninger
  • G. Schürmann
  • C. F. Krieglstein
Conference paper
Part of the Deutsche Gesellschaft für Chirurgie book series (DTGESCHIR, volume 31)

Abstract

Background: Very late antigen 4 (VLA-4; alpha 4 beta 1 integrin) is upregulated on the surface of circulating leukocytes in case of inflammation processes and mediates leukocyte firm adherence on endothelial cells by interaction with its ligand vascular cell adhesion molecule 1 (VCAM-1) [1]. We examined 1) if a monoclonal antibody (MAb) vs. VLA-4 reduces in vivo leukocyte adhesion and 2) if established colitis is reduced by blocking VLA-4 in a murine model of inflammatory bowel disease (IBD). Methods: Chronic colitis was induced in male balb/c mice (20 – 22 g) by oral administration of 3% dextrane sodium sulfate (DSS) [2]. In the first study, in 7 animals leukocyte adhesion was measured in a single colonic submucosal venule by intravital microscopy on day 30 [3]. Anti-VLA-4 (PS/2) 2 mg/kg was injected and leukocyte adhesion was observed for 60 min. In the second study mice were treated by daily i.p. injection of PS/2 2 mg/kg over 5 days. On day 30 disease activity index (DAI) and histology (Dieleman score [4]) were compared with a healthy and a diseased control group (n = 7). Furthermore, intravital microscopy was performed in 10 submucosal venules in the distal colon and leukocyte adhesion was evaluated. The Kruskal-Wallis test and Wilcoxon test were applied when appropriate (p < 0.05). Results: Leukocyte firm adherence was reduced several minutes after injection of PS/2 (16.0 ± 1.4 vs. 23.5 ± 2.2/0.01 mm2/30 s, p < 0.05) and further declined to 3.6 ± 1.0 at the end of the 60 min. Rolling leukocytes were diminished significantly from 154.2 ± 15.5 to 119.3 ±17.3 after 10 min of observation. Therapeutic treatment with anti-VLA-4 significantly reduced DAI (1.0 ±0.2 vs. 1.9 ±0.2 pts.), histological inflammation in the distal colon (13.5 ± 1.0 vs. 20.8 ±1.0 pts.) and the number of firm adherent leukocytes (1.8 ± 0.3 vs. 25.5 ± 3.7/0.01 mm2/30 s) compared to diseased controls. Rolling leukocytes were not reduced significantly. Conclusions: The VLA-4/VCAM-1 mediated leukocyte endothelial cell interaction plays a key role in the perpetuation of DSS-induced chronic colitis. VLA-4 has its major function in firm leukocyte adherence. Blockade of VLA-4 reduces established colitis and could thus become a therapeutical option in the treatment of patients with IBD.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Johnston B, Kubes P (1999) The alpha4-Integrin: An alternative pathway for neutrophil recruitment? Immunol Today 20: 545 - 550PubMedCrossRefGoogle Scholar
  2. 2.
    Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ (1993) Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin, Dig Dis Sci 38: 1722-34PubMedCrossRefGoogle Scholar
  3. 3.
    Krieglstein CF, Anthoni C, Laukötter MG, Rijcken E, Spiegel HU, Senninger N, Schürmann G (1999) Effect of anti-CDllb (alphaM-MAC-1) and anti-CD54 (ICAM-1) monoclonal antibodies on indomethacin induced chronic ileitis in rats. Int J Colorectal Dis 14: 219-223PubMedCrossRefGoogle Scholar
  4. 4.
    Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG, Van Rees EP (1998) Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114: 385-393PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • Mike G. Laukötter
    • 1
    • 4
  • E. Rijcken
    • 1
  • C. Anthoni
    • 1
  • S. Meier
    • 1
  • D. Vestweber
    • 2
  • N. Senninger
    • 1
  • G. Schürmann
    • 3
  • C. F. Krieglstein
    • 1
  1. 1.Klinik und Poliklinik für Allgemeine ChirurgieUniversitätsklinikumGermany
  2. 2.Zentrum für Molekularbiologie der EntzündungWestfälische Wilhelms-UniversitätMünsterGermany
  3. 3.Klinik für Allgemein-, Gefäß- und ViszeralchirurgieMedizinisches Zentrum ItzehoeGermany
  4. 4.Klinik und Poliklinik für Allgemeine Chirurgie, UniversitätsklinikumWestfälische Wilhelms-UniversitätMünsterGermany

Personalised recommendations